
Cancer Research at Novartis Oncology
This content is intended for non-U.S. journalists. U.S. journalists, please visit the U.S. Media Room
Research
Please visit the Novartis Oncology Pipeline, which includes compounds in all phases of development, starting with preclinical studies through large Phase III randomized trials.
Everolimus Press Releases
EVEROLIMUS CONTACT
Everolimus Materials
-
02-Dec-2011
mTOR Infographic -
02-Dec-2011
Breast Cancer Heritage Fact Sheet -
23-Sep-2011
Advanced Breast Cancer Infographic -
23-Sep-2011
TAMRAD Trial Fact Sheet -
08-Sep-2011
Tuberous Sclerosis Complex Fact Sheet
INC424 Press Releases
INC424 CONTACT
INC424 Materials
-
Dec-2011
JAK-STAT Pathway Backgrounder -
Jun-2011
Myelofibrosis Reference Guide for Journalists -
May-2011
COMFORT-I Clinical Trial Fact Sheet -
May-2011
COMFORT-II Clinical Trial Fact Sheet
SEARCH OUR WEBSITES
ABOUT NOVARTIS ONCOLOGY

We deliver a broad range of innovative therapies, cancer resources and oncology drugs to improve and extend the lives of cancer patients.
